The combination of relacorilant and nab-paclitaxel improved survival in platinum-resistant ovarian cancer following a break ...

Serous cystadenofibromas are rare, accounting for only about 1.7% of benign ovarian tumors. They are often discovered by chance during routine gynecological exams and usually do not cause symptoms.

Nomograms have a strong reputation as reliable predictive models that simplify statistical prediction models and guide ...

The FDA grants fast track designation to PHST001, an antibody targeting CD24, for advanced platinum-resistant and ...

While some of these tumors are benign ... Patients who don't suffer from its intensity will typically have ... What are the latest developments in the diagnosis and treatment of Ovarian Cancer?

Serous cystadenofibromas are rare, accounting for only about 1.7% of benign ovarian tumors. They are often discovered by chance during routine gynecological exams and usually do not cause symptoms.

Nomograms have a strong reputation as reliable predictive models that simplify statistical prediction models and guide ...

Seventy-seven patients with TC-resistant ovarian cancer were enrolled. Resistance to TC was defined as disease progression under treatment, absence of response after 6 cycles of TC, or early ...

"Today’s approval of AVMAPKI FAKZYNJA CO-PACK for patients with KRAS-mutated recurrent low-grade serous ovarian cancer represents not only the first-ever FDA-approved treatment specifically for ...

Most ovarian cysts are benign and naturally go away on their own without treatment. These cysts cause little, if any, symptoms. Home remedies like heat therapy can help ease any symptoms you do have.